# A Study to Assess Adverse Events and Change in Disease Activity When Intravenous (IV) Pivekimab Sunirine is Given in Combination With Oral Venetoclax and IV or Subcutaneous Azacitidine in Adult Participants With Acute Myeloid Leukemia (AML)

> clinical trial · VERIFIED · 2026-07-31

Status: RECRUITING · Sponsor: AbbVie · Condition: Acute Myeloid Leukemia

- Company: AbbVie
- Sector: Acute Myeloid Leukemia
- Primary source: https://clinicaltrials.gov/study/NCT07581002

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.